INSULIN Act of 2026
Summary
The INSULIN Act of 2026 (HR10227) was introduced on September 2, 2026, and referred to three committees. At this early procedural stage, no specific market impact can be identified. The bipartisan cosponsorship suggests potential legislative momentum, but the bill's actual provisions and funding mechanisms remain unknown.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The INSULIN Act is in the earliest legislative stage—introduced and referred to committees.
- 2.No bill text or specific policy mechanisms are available to assess market impact.
- 3.Bipartisan cosponsorship indicates potential for future progress, but no near-term investment signal.
Market Implications
No immediate market implications. The bill is at a procedural stage with no financial data or specific provisions to analyze. Investors should not adjust positions based on this introduction alone.
Full Analysis
The INSULIN Act of 2026 was introduced in the House on September 2, 2026, by Rep. DeGette (D-CO) with four bipartisan cosponsors. The bill was referred to the Committees on Energy and Commerce, Ways and Means, and Education and Workforce. This is an early-stage procedural action with no committee hearings, markups, or text released. The bill's title suggests it aims to address insulin pricing or access, but without actual text, the specific policy levers (price caps, rebate reforms, or insurance mandates) are unknown. No funding amount is authorized or appropriated. The legislative path requires committee consideration, potential amendments, floor votes, and Senate action—a process that typically takes months to years. Given the early stage, there is no actionable market signal for retail investors. If the bill advances, it could impact insulin manufacturers (LLY, NVO, SNY), pharmacy benefit managers (CVS, UNH, CI), and insurers, but no specific causal chain can be drawn now. Investors should monitor committee activity and bill text release for concrete analysis.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →